Short-term effects of empagliflozin on preventing contrast induced acute kidney injury in patients undergoing percutaneous coronary intervention, a randomised trial.

There was a clear trend toward a reduction in mean cystatin C levels in the empagliflozin users compared to the placebo post-intervention before and after intervention (p-value = 0.005).

also in 19,460 other papers